Effect of several hydrophilic polymers on the permeation of morphine and salicylic acid through excised hairless rat skin.
Several hydrophilic polymers changed the cumulative amount of morphine (MOR) permeated through excised hairless rat skin from 1% MOR hydrochloride solution containing ethanol and l-menthol at concentrations of 40% and 5%, respectively, as permeation enhancers. Anionic polymers (carboxyvinylpolymer and methylvinylether-maleic anhydride copolymer) in the test solutions decreased the skin permeation of MOR, whereas cationic polymers (polyethyleneimine and chitosan) increased it, compared with that without polymers. Little change, however, was observed by the addition of nonionic polymers (hydroxypropylcellulose and polyethyleneoxide). On the other hand, the cationic and anionic polymers in the test solutions decreased and increased, respectively, the skin permeation of salicylic acid (SA) from the same enhancing system containing sodium salicylate. These opposite results were probably caused by the change in escaping tendency of the drugs from the vehicles, which was due to the drug-polymer interaction. (The escaping tendency has a great effect on the drug partition from the polymer solution to the skin barrier). The effect of hydrophilic polymers on the partition was then evaluated by Donnan membrane theory. The partition of MOR was increased and decreased by the presence of polymers having identical and opposite charge to MOR. The low partition of the drugs to skin may also be caused by low diffusion of the drugs in the polymer solutions. The drug release from the hydrophilic polymer solutions was then measured, and the release rate was found to have decreased in the presence of polymers having opposite charge to MOR and SA. It is suggested that these drug-polymer interactions changed the drug partition to skin thus changing the skin permeation of the drug.
Hosoya
O
O
Research Institute of TTS Technology, Saitama, Japan.
Sano
M
M
Wada
Y
Y
Seki
T
T
Sugibayashi
K
K
Juni
K
K
Morimoto
Y
Y
D000701:Analgesics, Opioid / Q000493:pharmacokinetics*; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004058:Diffusion; D066298:In Vitro Techniques; D017551:Microdialysis; D009020:Morphine / Q000493:pharmacokinetics*; D011108:Polymers / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012459:Salicylates / Q000493:pharmacokinetics*; D020156:Salicylic Acid; D012869:Skin Absorption / Q000187:drug effects*; D014783:Viscosity
D000701:Analgesics, Opioid; D011108:Polymers; D012459:Salicylates; D009020:Morphine; D020156:Salicylic Acid